Seeking Alpha

JNJ settlement includes $485M in criminal fines and $1.72B in civil settlements

  • "This multibillion-dollar resolution demonstrates the Justice Department’s firm commitment to preventing and combating all forms of health care fraud," Attorney General Eric Holder says, regarding the $2.2B+ Johnson & Johnson (JNJ -0.8%) and its subsidiaries will pay to settle criminal and civil liability related to allegations of off-label marketing and physician kickbacks for Risperdal, Invega, and Natrecor.
  • Mentioned and outlined in the DOJ's PR: Janssen's alleged misbranding of Risperdal, the alleged "targeting of vulnerable patients with the drugs Risperdal and Invega for off-label uses," alleged "kickbacks to nursing homes," and alleged "off-label promotion" of Natrecor.
  • Full release
Comments (3)
  • $17B in earnings last quarter. Something tells me this is a drop in the bucket, particularly in light of what they probably collected based on all of this marketing
    4 Nov 2013, 10:56 PM Reply Like
  • No surprises here after their DePuy scandals. J&J's management are delinquent in their duties and have completely failed to control their various subsidiaries that stray into fraud at the cost of human suffering.
    5 Nov 2013, 02:14 AM Reply Like
  • It's been a great investment though these last few years. Amazing how little all of this negative press has affected the stock
    5 Nov 2013, 07:38 AM Reply Like
DJIA (DIA) S&P 500 (SPY)